$565 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | Sell | PFIZER INC | $44,642,000 | -9.8% | 1,139,985 | -16.5% | 7.91% | -12.8% |
| GILD | Sell | GILEAD SCIENCES INC | $39,758,000 | -9.4% | 577,368 | -14.9% | 7.04% | -12.3% |
| MRK | Sell | MERCK & CO. INC | $35,420,000 | -9.2% | 455,447 | -10.0% | 6.27% | -12.2% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $34,980,000 | +49.3% | 523,493 | +41.1% | 6.20% | +44.4% |
| MDT | Sell | MEDTRONIC PLC | $25,959,000 | -4.2% | 209,128 | -8.8% | 4.60% | -7.3% |
| BIIB | Buy | BIOGEN INC | $25,293,000 | +83.5% | 73,043 | +48.3% | 4.48% | +77.5% |
| INCY | Sell | INCYTE CORP | $23,905,000 | -13.8% | 284,145 | -16.7% | 4.23% | -16.6% |
| BRKR | Sell | BRUKER CORP | $23,299,000 | -4.1% | 306,650 | -18.8% | 4.13% | -7.2% |
| BDX | Sell | BECTON DICKINSON & CO | $23,025,000 | -7.0% | 94,681 | -7.0% | 4.08% | -10.0% |
| CAH | Buy | CARDINAL HEALTH INC | $21,062,000 | +6.9% | 368,931 | +13.7% | 3.73% | +3.3% |
| NUVA | Buy | NUVASIVE INC | $19,911,000 | +8.8% | 293,754 | +5.2% | 3.53% | +5.2% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $18,661,000 | +26.5% | 436,406 | +14.4% | 3.30% | +22.4% |
| ANTM | Sell | ANTHEM INC | $17,037,000 | -16.4% | 44,624 | -21.4% | 3.02% | -19.2% |
| CNC | Sell | CENTENE CORP DEL | $16,731,000 | -24.9% | 229,410 | -34.2% | 2.96% | -27.4% |
| CVS | Sell | CVS HEALTH CORP | $16,725,000 | -7.2% | 200,441 | -16.3% | 2.96% | -10.2% |
| OGN | New | ORGANON & CO | $16,711,000 | – | 552,232 | +100.0% | 2.96% | – |
| BAX | Sell | BAXTER INTL INC | $15,515,000 | -11.1% | 192,739 | -6.9% | 2.75% | -14.0% |
| ELAN | Sell | ELANCO ANIMAL HEALTH INC | $13,754,000 | +11.2% | 396,478 | -5.6% | 2.44% | +7.5% |
| HSIC | New | HENRY SCHEIN INC | $12,295,000 | – | 165,721 | +100.0% | 2.18% | – |
| LH | Sell | LABORATORY CORP AMER HLDGS | $12,012,000 | +3.0% | 43,547 | -4.8% | 2.13% | -0.4% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $10,511,000 | -48.5% | 263,488 | -42.0% | 1.86% | -50.2% |
| PKI | Sell | PERKINELMER INC | $10,448,000 | -30.7% | 67,661 | -42.4% | 1.85% | -33.0% |
| BIO | Sell | BIO RAD LABS INCcl a | $10,396,000 | -6.9% | 16,136 | -17.5% | 1.84% | -10.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $9,835,000 | +16.5% | 58,017 | -3.0% | 1.74% | +12.7% |
| PRGO | Sell | PERRIGO CO PLC | $9,387,000 | +13.2% | 204,732 | -0.1% | 1.66% | +9.5% |
| HOLX | New | HOLOGIC INC | $7,855,000 | – | 117,738 | +100.0% | 1.39% | – |
| QGEN | New | QIAGEN NV | $7,744,000 | – | 160,061 | +100.0% | 1.37% | – |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $7,402,000 | +41.4% | 1,705,553 | +11.4% | 1.31% | +36.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,754,000 | -16.9% | 68,964 | -24.8% | 1.02% | -19.6% |
| SAGE | New | SAGE THERAPEUTICS INC | $5,155,000 | – | 90,738 | +100.0% | 0.91% | – |
| JNJ | JOHNSON & JOHNSON | $4,942,000 | +0.2% | 30,000 | 0.0% | 0.88% | -3.1% | |
| PDCO | New | PATTERSON COS INC | $4,308,000 | – | 141,743 | +100.0% | 0.76% | – |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $4,277,000 | +45.8% | 29,211 | +32.8% | 0.76% | +41.2% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $3,045,000 | – | 234,916 | +100.0% | 0.54% | – |
| NVAX | New | NOVAVAX INC | $2,893,000 | – | 13,626 | +100.0% | 0.51% | – |
| REGN | REGENERON PHARMACEUTICALS | $2,723,000 | +18.0% | 4,876 | 0.0% | 0.48% | +13.9% | |
| LIVN | Sell | LIVANOVA PLC | $1,245,000 | -88.1% | 14,803 | -89.5% | 0.22% | -88.4% |
| CVAC | Exit | CUREVAC N V | $0 | – | -25,000 | -100.0% | -0.42% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -29,690 | -100.0% | -1.02% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -54,000 | -100.0% | -1.08% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -50,657 | -100.0% | -1.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.